Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017 ; volume:150 ; number:1 ; day:18 ; month:1 ; year:2024 ; pages:1-9 ; date:1.2024
Journal of cancer research and clinical oncology ; 150, Heft 1 (18.1.2024), 1-9, 1.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Reitmajer, Markus
Leiter-Stöppke, Ulrike
Nanz, Lena
Amaral, Teresa
Flatz, Lukas
Garbe, Claus
Forschner, Andrea
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-023-05533-0
- URN
-
urn:nbn:de:101:1-2404180713537.377860296875
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Reitmajer, Markus
- Leiter-Stöppke, Ulrike
- Nanz, Lena
- Amaral, Teresa
- Flatz, Lukas
- Garbe, Claus
- Forschner, Andrea
- SpringerLink (Online service)
Ähnliche Objekte (12)
Decreased Plasma Ascorbate Levels in Stage IV Melanoma Patients
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients
The cost of unresectable stage III or stage IV melanoma in Italy
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
Approaches to decision-making among late-stage melanoma patients: a multifactorial investigation
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma
Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
Decreased Plasma Ascorbate Levels in Stage IV Melanoma Patients
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients
The cost of unresectable stage III or stage IV melanoma in Italy
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
Approaches to decision-making among late-stage melanoma patients: a multifactorial investigation
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma
Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
Decreased Plasma Ascorbate Levels in Stage IV Melanoma Patients
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients
The cost of unresectable stage III or stage IV melanoma in Italy
Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
Approaches to decision-making among late-stage melanoma patients: a multifactorial investigation
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
Dysfunctional plasmacytoid dendritic cells but not NK cells in the peripheral blood of stage IV melanoma patients
Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma